Takeda 1Q: Top Line Beat Consensus – Development Pipeline Continues to Progress
Takeda's reported revenue for 1QFY03/23 grew 2.4% YoY and beat consensus by a huge 46% while OP fell below consensus. Takeda continues to push...
365 Views
Otsuka Holdings (4578 JP): Revenue Guidance Raise and New Products Line-Up Enhance Conviction
Otsuka has raised H1FY23 revenue guidance. However, profits will be negatively impacted by one-off charges. Guidance raise and new product line-up...
294 Views
Pfizer Inc (PFE US): What’s Lie Ahead of Comirnaty? Potential Blockbuster Drugs in Pipeline
By leveraging on windfall gains from COVID portfolio, Pfizer is developing additional growth spots for future revenue growth. Its pipeline and...
329 Views
TOPIX Rebalance: Flows at the Close on 29 June
The third and final tranche of the FFW methodology change for the TOPIX Index will be implemented at the close of trading on 29 June. One way flow...
770 Views
TOPIX Rebalance: Flows at the Close
The second tranche of the FFW methodology change for the TOPIX Index will be implemented at the close of trading today. One way flow is ~JPY 745bn...
637 Views